Our results indicate that NEU3 positively functions in the malignancy of cancer, at least upstream of Ras/MAPK and PI3K/AKT, and we believe that it represents a new avenue for the treatment of bladder cancer. The gene discussed is AKT1; the disease is urinary bladder cancer.